Training programs in genomic medicine for diverse students
Summer Undergraduate and Postbacc Experiences in Genomic Medicine (SUPER-GM)
This study is all about helping people from diverse backgrounds in Alabama learn more about genomic medicine, so they can better understand diseases and treatments, with the support of students from Historically Black Colleges and Universities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10987510 on NIH RePORTER |
What this research studies
This research focuses on enhancing genomic medicine by engaging and educating individuals from underrepresented backgrounds, particularly in Alabama. It aims to improve disease diagnosis, predict outcomes, and guide treatment through the involvement of students from Historically Black Colleges and Universities (HBCUs) and other institutions. The University of Alabama at Birmingham (UAB) is leading this initiative, leveraging its strong commitment to diversity and its established programs that support students from disadvantaged backgrounds in pursuing careers in biomedical fields.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include students from underrepresented backgrounds, particularly those pursuing education in genomic medicine.
Not a fit: Patients who are not students or who do not belong to underrepresented groups may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more diverse biomedical workforce and improved health outcomes for underrepresented populations.
How similar studies have performed: Previous initiatives aimed at increasing diversity in biomedical fields have shown success, indicating a positive outlook for this approach.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Lasseigne, Brittany Nicole — University of Alabama at Birmingham
- Study coordinator: Lasseigne, Brittany Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.